These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27002295)

  • 1. Topical Administration of β-1,3-Glucan to Modulate Allergic Conjunctivitis in a Murine Model.
    Lee HS; Kwon JY; Joo CK
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1352-60. PubMed ID: 27002295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical Application of Interleukin-28A Attenuates Allergic Conjunctivitis in an Ovalbumin-Induced Mouse Model.
    Chen J; Zhang J; Zhao R; Jin J; Yu Y; Li W; Wang W; Zhou H; Su SB
    Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):604-10. PubMed ID: 26886894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB/c mice.
    Shoji J; Sakimoto T; Muromoto K; Inada N; Sawa M; Ra C
    Jpn J Ophthalmol; 2005; 49(3):205-10. PubMed ID: 15944824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Traffic-related particulate matter aggravates ocular allergic inflammation by mediating dendritic cell maturation.
    Hwang M; Han S; Seo JW; Jeon KJ; Lee HS
    J Toxicol Environ Health A; 2021 Aug; 84(16):661-673. PubMed ID: 33998398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superoxide dismutase 3 attenuates experimental Th2-driven allergic conjunctivitis.
    Lee HJ; Kim BM; Shin S; Kim TY; Chung SH
    Clin Immunol; 2017 Mar; 176():49-54. PubMed ID: 28063939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory effects of galectin-1 on an IgE-mediated allergic conjunctivitis model.
    Mello CB; Ramos L; Gimenes AD; Andrade TR; Oliani SM; Gil CD
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):693-704. PubMed ID: 25574053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin suppresses ovalbumin-induced allergic conjunctivitis.
    Chung SH; Choi SH; Choi JA; Chuck RS; Joo CK
    Mol Vis; 2012; 18():1966-72. PubMed ID: 22876123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of annexin A1 in a model of experimental allergic conjunctivitis.
    Gimenes AD; Andrade TR; Mello CB; Ramos L; Gil CD; Oliani SM
    Exp Eye Res; 2015 May; 134():24-32. PubMed ID: 25795053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interferon-gamma in a mouse model of allergic conjunctivitis.
    Stern ME; Siemasko K; Gao J; Duong A; Beauregard C; Calder V; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3239-46. PubMed ID: 16123425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 4 signalling attenuates experimental allergic conjunctivitis.
    Chung SH; Choi SH; Cho KJ; Joo CK
    Clin Exp Immunol; 2011 May; 164(2):275-81. PubMed ID: 21391988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A eye drops inhibit fibrosis and inflammatory cell infiltration in murine type I allergic conjunctivitis without affecting the early-phase reaction.
    Shii D; Nakagawa S; Shinomiya K; Yoshimi M; Katsuta O; Oda T; Nakamura M
    Curr Eye Res; 2009 Jun; 34(6):426-37. PubMed ID: 19899977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Allergic Conjunctivitis Induced by House Dust Mite Extract From Dermatophagoides pteronyssinus.
    Lee YJ; Han SJ; Lee H; Kim JS; Seo KY
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1773-81. PubMed ID: 27074380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin attenuates Th2-driven experimental allergic conjunctivitis.
    Shin S; Lee JH; Lee HJ; Chang SY; Chung SH
    Clin Immunol; 2018 May; 190():1-10. PubMed ID: 29432811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fyn regulates eosinophil infiltration into the conjunctiva by downregulating the Th2 response.
    Fukushima A; Yamaguchi T; Ozaki A; Taniguchi T; Udaka K; Ueno H
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):1043-9. PubMed ID: 15838661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducing ocular allergy with beta-lactoglobulin: a new experimental model.
    Sari A; Dinc E; Yilmaz BC; Adiguzel U; Oztuna S; Tasdelen B
    Ophthalmic Res; 2010; 44(2):119-24. PubMed ID: 20523103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-C chemokine receptor 6 (CCR6) is crucial for Th2-driven allergic conjunctivitis.
    Chung SH; Chang SY; Lee HJ; Choi SH
    Clin Immunol; 2015 Dec; 161(2):110-9. PubMed ID: 26307432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR2 agonist ameliorates murine experimental allergic conjunctivitis by inducing CD4 positive T-cell apoptosis rather than by affecting the Th1/Th2 balance.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
    Biochem Biophys Res Commun; 2006 Jan; 339(4):1048-55. PubMed ID: 16337148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRPV1 Antagonist Suppresses Allergic Conjunctivitis in a Murine Model.
    Kwon JY; Lee HS; Joo CK
    Ocul Immunol Inflamm; 2018; 26(3):440-448. PubMed ID: 27726468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoring conjunctival tolerance by topical nuclear factor-κB inhibitors reduces preservative-facilitated allergic conjunctivitis in mice.
    Guzmán M; Sabbione F; Gabelloni ML; Vanzulli S; Trevani AS; Giordano MN; Galletti JG
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(9):6116-26. PubMed ID: 25190648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inhibitor peptide of toll-like receptor 2 shows therapeutic potential for allergic conjunctivitis.
    Xu C; He X; Liu W; Chen Y; Zhou C; Duan Z; Lu Q; Yan X; Zhang Z; Zheng R
    Int Immunopharmacol; 2017 May; 46():9-15. PubMed ID: 28246054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.